MediciNova shareholders reject proposal to increase authorized shares to 247M at 2026 annual meeting

MEDICINOVA INC

Class I directors Hikedi Nagao and Nicole Lemerond elected with ~20.9M and ~21.5M votes for, respectively.
BDO USA ratified as auditor for FY 2026 with 26.7M votes for, 1.9M against.
Proposal to increase authorized common shares from 100M to 247M failed with 22.2M for, 6.4M against; needed majority of outstanding shares.
Adjournment proposal approved with 22.7M for, 5.8M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.